-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Tenet Healthcare, Raises Price Target to $257

Benzinga·12/02/2025 12:35:40
Listen to the news
Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $238 to $257.